About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
QDEL
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Quidel Non-GAAP EPS of $0.90 beats by $0.34, revenue of $744M beats by $51.72M
- U.S. govt. to restart program to ship free at-home COVID tests
- Quidel Non-GAAP EPS of $0.26 in-line, revenue of $665.1M beats by $50.52M
- QuidelOrtho Q2 2023 Earnings Preview
- Medtech set for banner year after significant boost in H1 device approvals
- Program for free COVID tests is ending as U.S. pandemic emergency winds down
- WHO meeting is set to decide whether to end COVID emergency
- Quidel Non-GAAP EPS of $1.80 beats by $0.37, revenue of $846.1M beats by $73.94M
- Quidel Q1 2023 Earnings Preview
- QuidelOrtho forecasts Q1 revenue above estimates
- Biden signs bill to end COVID national emergency
- WHO chief expects COVID emergency to end this year
- Democratic senators urge U.S. to maintain free COVID tests under Medicare
- QuidelOrtho 2023 earnings per share, revenue guidance range includes consensus
- Quidel Non-GAAP EPS of $1.76 beats by $0.34, revenue of $866.5M beats by $90.69M
- Quidel Q4 2022 Earnings Preview
- WHO maintains public health emergency on COVID but sees pandemic at 'transition point'
- COVID-19 public health emergency extended by HHS, possibly for final time
- WHO sets Jan. 27 meeting to decide on COVID emergency
- QuidelOrtho guides Q4 revenue above consensus